These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15699121)

  • 1. High incidence of spontaneous disease in an HLA-DR15 and TCR transgenic multiple sclerosis model.
    Ellmerich S; Mycko M; Takacs K; Waldner H; Wahid FN; Boyton RJ; King RH; Smith PA; Amor S; Herlihy AH; Hewitt RE; Jutton M; Price DA; Hafler DA; Kuchroo VK; Altmann DM
    J Immunol; 2005 Feb; 174(4):1938-46. PubMed ID: 15699121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell response to myelin basic protein in the context of the multiple sclerosis-associated HLA-DR15 haplotype: peptide binding, immunodominance and effector functions of T cells.
    Vergelli M; Kalbus M; Rojo SC; Hemmer B; Kalbacher H; Tranquill L; Beck H; McFarland HF; De Mars R; Long EO; Martin R
    J Neuroimmunol; 1997 Aug; 77(2):195-203. PubMed ID: 9258250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells.
    Forsthuber TG; Shive CL; Wienhold W; de Graaf K; Spack EG; Sublett R; Melms A; Kort J; Racke MK; Weissert R
    J Immunol; 2001 Dec; 167(12):7119-25. PubMed ID: 11739534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease-related epitope spread in a humanized T cell receptor transgenic model of multiple sclerosis.
    Ellmerich S; Takacs K; Mycko M; Waldner H; Wahid F; Boyton RJ; Smith PA; Amor S; Baker D; Hafler DA; Kuchroo VK; Altmann DM
    Eur J Immunol; 2004 Jul; 34(7):1839-48. PubMed ID: 15214032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High immunogenicity of intracellular myelin oligodendrocyte glycoprotein epitopes.
    Weissert R; Kuhle J; de Graaf KL; Wienhold W; Herrmann MM; Müller C; Forsthuber TG; Wiesmüller KH; Melms A
    J Immunol; 2002 Jul; 169(1):548-56. PubMed ID: 12077287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
    Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
    Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hla-DR2-restricted responses to proteolipid protein 95-116 peptide cause autoimmune encephalitis in transgenic mice.
    Kawamura K; Yamamura T; Yokoyama K; Chui DH; Fukui Y; Sasazuki T; Inoko H; David CS; Tabira T
    J Clin Invest; 2000 Apr; 105(7):977-84. PubMed ID: 10841661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of EAE by spontaneously generated IL-10-secreting regulatory T cells in HLA-DR15/TCR.Ob1A12 double transgenic mice.
    Leno-Durán E; Ng SL; Strominger JL
    Immunology; 2021 Jul; 163(3):338-343. PubMed ID: 33565605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuated immune control of Epstein-Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15.
    Zdimerova H; Murer A; Engelmann C; Raykova A; Deng Y; Gujer C; Rühl J; McHugh D; Caduff N; Naghavian R; Pezzino G; Capaul R; Zbinden A; Ferlazzo G; Lünemann JD; Martin R; Chatterjee B; Münz C
    Eur J Immunol; 2021 Jan; 51(1):64-75. PubMed ID: 32949466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP).
    Kaushansky N; Altmann DM; David CS; Lassmann H; Ben-Nun A
    J Neuroinflammation; 2012 Feb; 9():29. PubMed ID: 22316121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells.
    Kim YC; Zhang AH; Yoon J; Culp WE; Lees JR; Wucherpfennig KW; Scott DW
    J Autoimmun; 2018 Aug; 92():77-86. PubMed ID: 29857928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A human leucocyte antigen-DR1 transgene confers susceptibility to experimental allergic encephalomyelitis elicited by an epitope of myelin basic protein.
    Sireci G; Dieli F; Caccamo N; Barera A; Carta P; Di Sano C; Meraviglia S; Bonanno CT; Salerno A
    Scand J Immunol; 2003 Aug; 58(2):188-94. PubMed ID: 12869140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease.
    Stüve O; Youssef S; Slavin AJ; King CL; Patarroyo JC; Hirschberg DL; Brickey WJ; Soos JM; Piskurich JF; Chapman HA; Zamvil SS
    J Immunol; 2002 Dec; 169(12):6720-32. PubMed ID: 12471103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitope spreading is not required for relapses in experimental autoimmune encephalomyelitis.
    Jones RE; Bourdette D; Moes N; Vandenbark A; Zamora A; Offner H
    J Immunol; 2003 Feb; 170(4):1690-8. PubMed ID: 12574332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DQB1*0602 determines disease susceptibility in a new "humanized" multiple sclerosis model in HLA-DR15 (DRB1*1501;DQB1*0602) transgenic mice.
    Kaushansky N; Altmann DM; Ascough S; David CS; Lassmann H; Ben-Nun A
    J Immunol; 2009 Sep; 183(5):3531-41. PubMed ID: 19648275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The myelin-associated oligodendrocytic basic protein (MOBP) as a relevant primary target autoantigen in multiple sclerosis.
    Kaushansky N; Eisenstein M; Zilkha-Falb R; Ben-Nun A
    Autoimmun Rev; 2010 Feb; 9(4):233-6. PubMed ID: 19683076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presentation of the self antigen myelin basic protein by dendritic cells leads to experimental autoimmune encephalomyelitis.
    Dittel BN; Visintin I; Merchant RM; Janeway CA
    J Immunol; 1999 Jul; 163(1):32-9. PubMed ID: 10384096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DRB1*1501 risk association in multiple sclerosis may not be related to presentation of myelin epitopes.
    Finn TP; Jones RE; Rich C; Dahan R; Link J; David CS; Chou YK; Offner H; Vandenbark AA
    J Neurosci Res; 2004 Oct; 78(1):100-14. PubMed ID: 15372502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-reactive TCR responses to self antigens presented by different MHC class II molecules.
    Mycko MP; Waldner H; Anderson DE; Bourcier KD; Wucherpfennig KW; Kuchroo VK; Hafler DA
    J Immunol; 2004 Aug; 173(3):1689-98. PubMed ID: 15265898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The T cell response of HLA-DR transgenic mice to human myelin basic protein and other antigens in the presence and absence of human CD4.
    Altmann DM; Douek DC; Frater AJ; Hetherington CM; Inoko H; Elliott JI
    J Exp Med; 1995 Mar; 181(3):867-75. PubMed ID: 7532684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.